Comparing treatments for urinary tract infections in pregnant women
Comparison of Antimicrobial Safety and Effectiveness for the Treatment of Urinary Tract Infections During Pregnancy
This study is looking at how safe and effective different medications are for treating urinary tract infections in pregnant women, and it aims to help doctors choose the best treatment based on whether or not patients have symptoms.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11076182 on NIH RePORTER |
What this research studies
This research investigates the safety and effectiveness of different antimicrobial treatments for urinary tract infections (UTIs) during pregnancy. It aims to compare the most commonly prescribed antimicrobials and assess how treatment choices may vary based on whether patients are experiencing symptoms. Additionally, the study will develop algorithms to help identify UTIs in large healthcare databases, which could improve future research and treatment options. By analyzing data from a cohort of pregnant women, the research seeks to provide clearer guidance for healthcare providers and patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women who are experiencing urinary tract infections.
Not a fit: Patients who are not pregnant or those who do not have urinary tract infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for pregnant women suffering from UTIs, reducing risks associated with these infections.
How similar studies have performed: Previous research has shown that comparative effectiveness studies can significantly improve treatment guidelines, suggesting that this approach may yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Kahrs, Jacob — Univ of North Carolina Chapel Hill
- Study coordinator: Kahrs, Jacob
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.